Ibogaine and the inhibition of acetylcholinesterase
Mechanisms In vitro low
AI-extracted · unverified · confirm at source
NOVEL MECHANISM: Ibogaine inhibits acetylcholinesterase, contributing to muscarinic cholinergic effects. Adds to multi-receptor profile and may explain some pharmacological/toxicological properties.
Dosing: N/A (IC₅₀ = 520 ± 40 µM for AChE inhibition) (not-specified)